Microwave ablation for hepatic malignancies: A multiinstitutional analysis

Annals of Surgery

Volumn 259, Issue 6, 2014, Pages 1195-1200

  Groeschl, Ryan T ^a   Pilgrim, Charles H C ^a   Hanna, Erin M ^b   Simo, Kerri A ^b   Swan, Ryan Z ^b   Sindram, David ^b   Martinie, John B ^b   Iannitti, David A ^b   Bloomston, Mark ^c   Schmidt, Carl ^c   Khabiri, Hooman ^c   Shirley, Lawrence A ^c   Martin, Robert C G ^d   Tsai, Susan ^a   Turaga, Kiran K ^a   Christians, Kathleen K ^a   Rilling, William S ^a   Gamblin, T Clark ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d University of Louisville School of Medicine   (United States)

Author keywords

Cancer; Colon; Rectal; Surgery; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CEREBROVASCULAR ACCIDENT; COLORECTAL LIVER METASTASIS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HEALTH CENTER; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; KIDNEY FAILURE; LAPAROSCOPIC SURGERY; LIVER ABSCESS; LIVER CANCER; LIVER CELL CARCINOMA; LIVER RESECTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MICROWAVE THERAPY; MULTIMODALITY CANCER THERAPY; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; SURGICAL APPROACH; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DIATHERMY; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MICROWAVES; MIDDLE AGED; NEOPLASM METASTASIS; PROPENSITY SCORE; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84900873256     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000234     Document Type: Article

References (32)

1. Wong SL, Mangu PB, Choti MA, et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 2010;28: 493-508
2. Li L, Zhang J, Liu X, et al. Clinical outcomes of radiofrequency ablation and surgical resection for small hepatocellular carcinoma: A meta-Analysis. J Gastroenterol Hepatol. 2012;27:51-58
3. Tiong L, Maddern GJ. Systematic review and meta-Analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg. 2011;98:1210-1224
4. Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: Principles and applications. Radiographics. 2005;25:S69-S83
5. Ohmoto K, Miyake I, Tsuduki M, et al. Percutaneous microwave coagulation therapy for unresectable hepatocellular carcinoma. Hepatogastroenterology. 1999;46:2894-2900
6. Seki T,Wakabayashi M, Nakagawa T, et al.Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer. 1994;74:817-825
7. Tsai S, Pawlik TM. Outcomes of ablation versus resection for colorectal liver metastases: Are we comparing apples with oranges?. Ann Surg Oncol. 2009;16:2422-2428
8. Andreano A, Brace CL. A comparison of direct heating during radiofrequency and microwave ablation in ex vivo liver. Cardiovasc Intervent Radiol. 2012;36:505-511
9. Andreano A, Huang Y, Meloni MF, et al. Microwaves create larger ablations than radiofrequency when controlled for power in ex vivo tissue. Med Phys. 2010;37:2967-2973
10. FanW, Li X, Zhang L, et al. Comparison of microwave ablation and multipolar radiofrequency ablation in vivo using two internally cooled probes. AJR Am J Roentgenol. 2012;198:W46-W50
11. Shock SA, Meredith K, Warner TF, et al. Microwave ablation with loop antenna: In vivo porcine liver model. Radiology. 2004;231:143-149
12. Groeschl RT, Wong RK, Quebbeman EJ, et al. Recurrence after microwave ablation of liver malignancies: A single institution experience. HPB (Oxford). 2013;15:365-371
13. Iannitti DA, Martin RC, Simon CJ, et al. Hepatic tumor ablation with clustered microwave antennae: The US Phase II trial. HPB (Oxford). 2007;9: 120-124
14. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213
15. Cauchy F, Fuks D, Belghiti J. HCC: Current surgical treatment concepts. Langenbecks Arch Surg. 2012;397:681-695
16. Clavien PA, Lesurtel M, Bossuyt PM, et al. Recommendations for liver transplantation for hepatocellular carcinoma: An international consensus conference report. Lancet Oncol. 2012;13:e11-e22
17. De Lope CR, Tremosini S, Forner A, et al. Management of HCC. J Hepatol. 2012;56(Suppl):S75-S87
18. GroeschlRT, Clark Gamblin T, Turaga KK. Surgical resection in hepatocellular carcinoma patients with minimal background fibrosis: A strategy in the era of organ shortage. Ann Surg Oncol. 2013;20:2043-2048
19. Groeschl RT, Nachmany I, Steel JL, et al. Hepatectomy for noncolorectal nonneuroendocrine metastatic cancer: A multi-institutional analysis. J Am Coll Surg. 2012;214:769-777
20. Pawlik TM, Choti MA. Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg. 2007;11:1057-1077
21. Sarmiento JM,Heywood G, Rubin J, et al. Surgical treatment of neuroendocrine metastases to the liver: A plea for resection to increase survival. J Am Coll Surg. 2003;197:29-37
22. Gamblin TC, Geller DA. Downstaging hepatocellular carcinoma prior to liver transplantation. Liver Transpl. 2005;11:1466-1468
23. Heckman JT, Devera MB, Marsh JW, et al. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Ann Surg Oncol. 2008;15:3169-3177
24. JonesC,Badger SA, Ellis G. The role ofmicrowave ablation in the management of hepatic colorectal metastases. Surgeon. 2011;9:33-37
25. Liang P, Yu J, Yu XL, et al. Percutaneous cooled-Tip microwave ablation under ultrasound guidance for primary liver cancer: A multicentre analysis of 1363 treatment-naive lesions in 1007 patients in China. Gut. 2011;61:1100-1101
26. Martin RC, Scoggins CR, McMasters KM. Safety and efficacy of microwave ablation of hepatic tumors: A prospective review of a 5-year experience. Ann Surg Oncol. 2010;17:171-178
27. Kuyvenhoven J, Lamers CB, Van Hoek B. Practical management of hepatocellular carcinoma. Scand J Gastroenterol Suppl. 2001;234:82-87
28. Swan RZ, Sindram D, Martinie JB, et al. Operative microwave ablation for hepatocellular carcinoma: Complications, recurrence, and long-Termoutcomes. J Gastrointest Surg. 2013;17:719-729
29. vanVledderMG, Pawlik TM,Munireddy S, et al. Factors determining the sensitivity of intraoperative ultrasonography in detecting colorectal liver metastases in the modern era. Ann Surg Oncol. 2010;17:2756-2763
30. Brouquet A, Abdalla EK, Kopetz S, et al. High survival rate after two-stage resection of advanced colorectal livermetastases: Response-based selection and complete resection define outcome. J Clin Oncol. 2011;29:1083-1090
31. Simo KA, Tsirline VB, Sindram D, et al. Microwave ablation using 915-MHz and 2.45-GHz systems: What are the differences?. HPB (Oxford). 2013;15: 991-996
32. Lloyd DM, Lau KN,Welsh F, et al. International multicentre prospective study on microwave ablation of liver tumours: Preliminary results. HPB (Oxford). 2011;13:579-585.